Skip to Main Content

Paper Details

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
Neuro Oncol
48
2017
AGGF1, D341, D425, Group, Group 3, Group 3 medulloblastoma, MYC, PROK2, Patient, RNA, RNH1, SCG2, Tumor, VEGFA, VEGFA mRNA, Xenografts D283, intratumoral, medulloblastoma, nude rats, patient, patients, rat, rat VEGFA, rat vascular endothelial growth factor alpha, tumor
Author NameAffiliation
Stephen T KeirDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Talaignair N VenkatramanDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Christopher D LascolaDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Daniel PicardDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Marc RemkeDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Darell D BignerDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Vijay RamaswamyDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Michael D TaylorDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Michael D TaylorDuke University, Stanford University, and Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium and German Cancer Research Center, the Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
  • 1 - 9

Datasets